SSA
MRK icon

Schonfeld Strategic Advisors’s Merck MRK Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-176,000
Closed -$14.8M – 2390
2025
Q3 		$14.8M Buy
+176,000
New +$14.5M 0.08% 254
2021
Q4 		– Sell
-100,000
Closed -$7.51M – 2394
2021
Q3 		$7.51M Buy
+100,000
New +$7.61M 0.08% 328

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schonfeld Strategic Advisors's MRK Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its Merck (MRK) stake by 60% in Q1 2026, selling an estimated $6M and leaving 34,694 shares worth $4.17M. The position accounts for 0.03% of the portfolio, ranked #550.

Schonfeld Strategic Advisors first reported a position in MRK in Q2 2016 and has held it in 35 quarters since. The position peaked at $50.9M in Q1 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Schonfeld Strategic Advisors held 34,694 shares of Merck worth $4.17M as of Q1 2026.
  • Schonfeld Strategic Advisors sold 51,961 Merck shares in Q1 2026, an estimated $6M.
  • Merck made up 0.03% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #550 holding.
  • Schonfeld Strategic Advisors first reported a position in Merck in Q2 2016 and has held it in 35 quarters since.
  • Schonfeld Strategic Advisors's Merck position peaked at $50.9M in Q1 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.